We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| EV3 (MM) | NASDAQ:EVVV | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 22.56 | 0 | 01:00:00 |
From Sep 2019 to Sep 2024
To access the webcast, go to the investor relations section of the ev3 Web site at http://ir.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developing innovative and breakthrough technologies for the endovascular treatment of peripheral vascular and neurovascular diseases. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- plaque excision systems, peripheral angioplasty balloons, stents, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.
CONTACT: ev3 Inc.INVESTORS and MEDIA
Julie Tracy, Sr. Vice President, Chief Communications Officer
(949) 680-1375
jtracy@ev3.net
1 Year EV3 (MM) Chart |
1 Month EV3 (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
